Gail Cohen | VP, Corporate Communications and IR |
Rick Winningham | CEO |
Frank Pasqualone | Chief Commercial Operations Officer |
Brett Haumann | Chief Medical Officer |
Andrew Hindman | CFO |
Geoffrey Porges | SVB Leerink |
Marc Frahm | Cowen |
Douglas Tsao | H.C. Wainwright |
Liisa Bayko | Evercore ISI |
Anupam Rama | JPMorgan |
Vikram Purohit | Morgan Stanley |
Brian Skorney | Baird |
Joseph Stringer | Needham and Company |
Ladies and gentlemen, good afternoon. I'd like to welcome everyone to the Theravance Biopharma Fourth Quarter and Full Year 2020 Conference Call.
During the presentation, all participants will be in a listen-only mode. A question-and-answer session will follow the company's formal remarks. [Operator Instructions] Also, today's conference call is being recorded.